# Doctorsa S.r.l.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/doctorsa-s-r-l

- Industry: Healthcare IT
- Headquarters: Milan, Italy
- Website: www.doctorsa.com/
- Total disclosed funding: $1.1M
- Latest round: Seed (Jul 13, 2026)
- Investors on record: 3

## About

Doctorsa S.r.l., based in Milan, Italy, provides a telehealth platform delivering urgent and primary care services to international travelers, ensuring accessible medical consultations through technology.Founded in 2018, Doctorsa S.r.l. is a telehealth service that facilitates prompt medical consultations for travelers. The company has successfully executed one deal, with the latest funding round taking place on July 13, 2026. Doctorsa raised EUR 1 million in this round, led by Prana Ventures, with participation from Vento Ventures and 40Jemz Ventures.Doctorsa offers a comprehensive telehealth platform designed for travelers in need of urgent and primary care services. The company's core offerings include video consultations with licensed physicians, enabling users to receive medical advice and prescriptions swiftly from anywhere in the world via their smartphones. Customers can submit requests detailing their medical concerns, such as symptoms like sore throats or urinary tract infections, and receive personalized responses from qualified doctors within minutes. The platform is available globally, with a focus on major markets including Europe, the United Kingdom, Turkey, Mexico, Brazil, Argentina, Vietnam, Thailand, and Indonesia. By facilitating a stress-free healthcare experience with clear and affordable pricing—averaging around 25 Euros per online consultation—Doctorsa caters to a diverse clientele of international travelers seeking timely medical assistance without the complexities of traditional healthcare systems.Doctorsa generates revenue through a straightforward transaction structure, primarily involving pay-per-visit fees for telehealth services. Customers pay for individual consultations, which typically start at around 25 Euros, allowing them to access a network of healthcare providers who compete for their business by offering personalized care options. The company operates on a direct-to-consumer model, where users can choose their preferred doctor based on credentials, ratings, and pricing. Following each consultation, doctors send prescriptions directly to patients via email, with the option for patients to purchase medications at local pharmacies. The platform’s design emphasizes affordability and accessibility, ensuring that users can efficiently manage their healthcare needs while traveling, thus solidifying its position in the growing telehealth market.In July 2026, Doctorsa raised EUR 1 million in venture funding to bolster its operations. The company plans to use this funding to strengthen its position in existing markets while exploring expansion into new international markets. Specific geographic regions targeted for future growth have not been disclosed, but the emphasis will be on enhancing service delivery and customer engagement.

## Funding rounds

- Seed, Jul 13, 2026, $1.1M — Prana Ventures, Vento Ventures, 40Jemz Ventures

## Investors

- Prana Ventures (https://capitalatlas.ai/funds/prana-ventures) — Seed
- Vento Ventures (https://capitalatlas.ai/funds/vento-ventures) — Seed
- 40Jemz Ventures (https://capitalatlas.ai/funds/40jemz-ventures) — Seed